Reverse-phase HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-11. Anything still debated is marked as such rather than presented as settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming is inconsistent across suppliers and publications |
| Reported sequence | Ac-LKKTETQ | Corresponds to residues 17-23 of the parent protein |
| Frequently cited registry number | 77591-33-4 | Associated with full-length thymosin beta-4 rather than the fragment |
| Common supplied form | Freeze-dried solid | Often presented as an acetate or trifluoroacetate salt |
| Regulatory treatment | Varies by country | Frequently handled as a research chemical; not broadly approved as a therapeutic |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
== Awards == Gold medal awarded inventor of Hungary (1986) Award for outstanding research work from Hungarian Academy of Sciences (1988) Debio Peptide Award of the 22nd European Peptide Symposium for the development of novel selective antitumor peptide hormones (1992) Széchenyi Professorship of the Ministry of Education and Culture (1996) Queensland University Research Award (2000) "The Academic Award" of the Hungarian Academy of Sciences (2002) Jedlik Ányos Award (2008) Outstanding Innovation Award of Hungarian Academy Sciences and Hungarian Patent Office (2010) Széchenyi Prize (2013)
=== Allergy diagnosis === Basophils are easily isolated from venous blood and present good "indicator cells" of an IgE-mediated allergic response based on the upregulation of activation markers such as CD63 and/or CD203c upon suspect allergen stimulation. Therefore, the BAT serves to confirm IgE-mediated allergy following uncertain results from classical testing based on anamnesis, skin testing or specific IgE results. More recently, BAT has also been used for the monitoring of successful allergen immunotherapy (desensitization) to differentiate short-term desensitization versus sustained unresponsiveness to the allergen.
== Equilibria Among Multiple Reactions == Consider the case of a dibasic acid H2A. When dissolved in water, the mixture will contain H2A, HA− and A2−. This equilibrium can be split into two steps in each of which one proton is liberated.
26 April A firebase occupied by a unit of the 1st Brigade, 25th Infantry Division 20 km south of Tây Ninh was hit by 300 rounds of 82mm mortar and 107mm rocket fire and then attacked by an estimated two PAVN/VC battalions. The base was supported by artillery and helicopter and fixed wing gunships and 213 PAVN/VC were killed, six captured and 35 individual and 15 crew-served weapons captured.
Sources: en.wikipedia.org
=== Frabelle Fishing Corporation === Tiu Laurel became the president of the Frabelle Fishing Corporation in 1985 and its director in 2010. The family-owned business, which was established by Tiu Laurel's parents in 1966, is engaged in a variety of business interests in the agricultural and fisheries industry, such as deep-sea fishing, aquaculture, canning, meat and seafood processing, cold-chain network, shipbuilding and repair, and power generation. Frabelle operates in the Asia-Pacific region and supplies domestically in the Philippines and internationally. Concurrently, Tiu Laurel served as President of the Confederation of the Philippine Tuna Industry from 2002 to 2006, director of the Interland Deep Sea Fishing Sector, director of the World Tuna Purse Seine Organization, and chairman of the Processing Sector of Bangus (Milkfish) Council of the Philippines.
The French Armed Forces 24-hour combat ration, the RCIR (French: Ration de Combat Individuelle Réchauffable) comes in 14 menus packed in a small cardboard box. Inside are two pre-cooked, ready-to-eat meal main courses packed in thin metal cans somewhat like oversized sardine tins, and an hors d'oeuvre in a more conventional can or tin. Current main courses include items such as beef salad, tuna and potatoes, salmon with rice and vegetables, shepherd's pie, rabbit casserole, chili con carne, paella, veau marengo (veal), navarin d'agneau (lamb), poultry and spring vegetables, etc. Hors d'oeuvres include: salmon terrine, chicken liver, tuna in sauce, fish terrine, duck mousse, etc. Each meal box also contains a package of instant soup, hard crackers, cheese spread, chocolate, caramels or boiled sweets, instant café-au-lait, sugar, cocoa powder, matches, a disposable folding ration heater and fuel tablets, and water purifying tablets.
Approximately 152,000 such individuals participated in the plebiscite. However, debate went on whether it was a Polish or German condition at Versailles, since it might have been expected that many Ruhr Area Poles would vote for Poland as well. Therefore, it is also reported that the Polish delegation planned to bring Polish émigrés not only from other parts of Germany, but also from America, to the plebiscite area to strengthen their position, but those plans were not executed. The Polish delegation claimed that was a German condition. According to Richard K. Debo, both the German and the Polish governments believed that the outcome of the plebiscite had been decided by the ongoing Polish-Bolshevik War, which threatened the very existence of the newly-formed Polish state itself and so many Poles in the region voted for Germany for fear that if the area joined Poland, it would soon fall under Soviet rule. During the plebiscite, the Red Army came closer to Warsaw every day and committed crimes against the civilian population. According to several Polish sources, the Germans engaged in a massive persecution of Polish activists and their Masurian supporters and went as far as engaging in regular hunts and murder to influence the vote. The organisation of the plebiscite was also influenced by Britain, which supported Germany out of fear of an increased power for France in postwar Europe. According to Jerzy Minakowski, terror and their unequal status made Poles boycott the preparations for the plebiscite, which allowed the Germans to add ineligible voters.
ribose A monosaccharide sugar which, as D-ribose in its pentose ring form, is one of three primary components of the ribonucleotides from which ribonucleic acid (RNA) molecules are built. Ribose differs from its structural analog deoxyribose only at the 2' carbon, where ribose has an attached hydroxyl group that deoxyribose lacks.
The fundamental advantage of an integrated graphene-CNT structure is the high surface area three-dimensional framework of the CNTs coupled with the high edge density of graphene. Depositing a high density of graphene foliates along the length of aligned CNTs can significantly increase the total charge capacity per unit of nominal area as compared to other carbon nanostructures. Cup-stacked carbon nanotubes (CSCNTs) differ from other quasi-1D carbon structures, which normally behave as quasi-metallic conductors of electrons. CSCNTs exhibit semiconducting behavior because of the stacking microstructure of graphene layers.
Sources: en.wikipedia.org
=== 12 July === In Donetsk Oblast, four people were killed by Russian shelling in Pokrovsk, while two others were also killed by shelling in Kostyantynivka. France permitted its weapons to be used by Ukraine against military targets on Russian soil, provided they pose a threat to Ukraine and that the Kremlin would not be targeted. Ukraine struck a Russian S-300V air defence system near Mariupol Airport.
Additionally, CAM providers are concerned by the closure of other CAM laboratories under CLIA, and have sought to avoid detection. Some CAM providers and laboratory personnel have not had exposure to laboratory curriculum and are unaware of CLIA requirements. CLIA is largely reliant on laboratories to self-identify themselves for enrollment. Providers of CAM laboratories have opposed CLIA oversight and suggested they be regulated by their peers or by a CAM-specific division. CAM providers have stated that they should be exempt from CLIA since CAM laboratories do not participate in health insurance. Others claim that they are exempt from CLIA because the tests are performed solely for research purposes and not used in patient care and treatment decisions. Several pathologists have stated that CAM testing falls within the scope of their medical license and should not be regulated under CLIA. CLIA provisions are geared towards CLIA-certified laboratories, but not for those that have not enrolled. When a CAM laboratory is found to be operating without a CLIA certificate, they are sent a cease and desist letter to stop testing until the laboratory is CLIA certified. There are no administrative remedies available to CMS when a laboratory refuses to enroll in CLIA and refuses to cease testing. CMS cannot impose monetary or other administrative penalties on laboratories that defy the law, but can only refer cases to other Federal or State agencies.
== Veterinary use == Buprenorphine is commonly used as a long-lasting post-operative analgesic in small animal veterinary practice. Buprenorphine can be administered via subcutaneous, transdermal, intravenous, or intramuscular routes. Buprenorphine provides analgesia for 6–8 hours in dogs and 4–8 hours in cats when administered as an intramuscular or intravenous injection. Buprenorphine as a partial agonist of the mu-receptor has less adverse effects than full agonists. A transdermal application can provide analgesia for up to 4 days in cats. The oral-transmucosal route has been investigated due to the potential for client administration but variability in bio-availability and other issues limit this usage. When used in combination with local anaesthetics or a non-steroidal anti-inflammatory drug buprenorphine provides good analgesia for ovariohysterectomies and orchidectomies. In horses buprenorphine can be used for castration and dental extraction; however, buprenorphine is not commonly used in horses as a post-operative analgesic due to potential for adverse gastrointestinal effects and locomotive stimulation. Buprenorphine is commonly given alongside acepromazine or a2 adrenergic receptor agonists
18-Methoxycoronaridine (18-MC; developmental code name MM-110), also known as zolunicant (INNTooltip International Nonproprietary Name), is a derivative of ibogaine invented in 1996 by the research team around the pharmacologist Stanley D. Glick from the Albany Medical College and the chemists Upul K. Bandarage and Martin E. Kuehne from the University of Vermont. 18-MC was originally developed by Savant HWP and later acquired by MindMed in 2019 for development as a treatment for opioid use disorder. A Phase 1 trial in healthy volunteers was completed in 2022 with favorable safety and tolerability. Due to strategic reprioritization, MindMed discontinued active development of MM-110 in 2023 and has been seeking non-dilutive funding or partners to potentially restart the program; as of 2025 the program remains shelved. A separate Phase 2 trial in Brazil for cutaneous leishmaniasis (initiated 2017) has unknown status with no published results.
=== The Escherichia coli Metabolome Database === The E. Coli Metabolome Database is a freely accessible, online database of >2,700 small molecule metabolites found in or produced by Escherichia coli (E. coli strain K12, MG1655). The ECMDB contains two kinds of information:
Sources: en.wikipedia.org
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.
Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.
Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.